LYST
Basic information
Region (hg38): 1:235661041-235883724
Previous symbols: [ "CHS1" ]
Links
Phenotypes
GenCC
Source:
- Chediak-Higashi syndrome (Definitive), mode of inheritance: AR
- Chediak-Higashi syndrome (Strong), mode of inheritance: AR
- Chediak-Higashi syndrome (Strong), mode of inheritance: AR
- Chediak-Higashi syndrome (Supportive), mode of inheritance: AR
- attenuated Chédiak-Higashi syndrome (Supportive), mode of inheritance: AR
- Chediak-Higashi syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Chediak-Higashi syndrome | AR | Allergy/Immunology/Infectious; Hematologic; Oncologic | Individuals can have infection susceptibility, and prophylaxis and early and aggressive treatment of infections can be beneficial; Surveillance for hematologic complications and malignancy is warranted; For the accelerated phase, chemoimmunotherapy then transition to continuation therapy can be beneficial; For bleeding, platelet transfusions and DDAVP may be beneficial to prevent and/or treat episodes; BMT/HSCT has been described | Allergy/Immunology/Infectious; Dermatologic; Hematologic; Neurologic; Oncologic | 13584476; 5908967; 5156632; 5064229; 711501; 2697195; 2070553; 2058369; 8030398; 8701696; 9215680; 10422800; 10527680; 11857544; 15790783; 20503323; 20301751; 21488161; 23521865; 24521565 |
ClinVar
This is a list of variants' phenotypes submitted to
- Chédiak-Higashi syndrome (91 variants)
- Chediak-Higashi syndrome, childhood type (3 variants)
- Inborn genetic diseases (2 variants)
- Thrombocytopenia;Abnormal bleeding (1 variants)
- LYST-related disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LYST gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 16 | 926 | 13 | 955 | ||
missense | 1332 | 27 | 1370 | |||
nonsense | 48 | 36 | 86 | |||
start loss | 0 | |||||
frameshift | 43 | 32 | 76 | |||
inframe indel | 24 | 25 | ||||
splice donor/acceptor (+/-2bp) | 27 | 29 | ||||
splice region | 36 | 114 | 3 | 153 | ||
non coding | 39 | 407 | 123 | 569 | ||
Total | 93 | 100 | 1415 | 1360 | 142 |
Highest pathogenic variant AF is 0.0000197
Variants in LYST
This is a list of pathogenic ClinVar variants found in the LYST region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-235661079-G-T | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235661109-T-G | Chédiak-Higashi syndrome | Conflicting classifications of pathogenicity (Nov 01, 2022) | ||
1-235661148-T-C | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235661217-T-C | Chédiak-Higashi syndrome | Benign (Apr 27, 2017) | ||
1-235661407-C-T | Chédiak-Higashi syndrome | Uncertain significance (Jan 12, 2018) | ||
1-235661441-C-A | Chédiak-Higashi syndrome | Benign (Jan 13, 2018) | ||
1-235661502-G-A | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235661512-A-C | Chédiak-Higashi syndrome | Uncertain significance (Jan 12, 2018) | ||
1-235661561-C-G | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235661584-C-A | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235661645-A-G | Chédiak-Higashi syndrome | Conflicting classifications of pathogenicity (Dec 01, 2022) | ||
1-235661665-A-G | Chédiak-Higashi syndrome | Benign (Jan 12, 2018) | ||
1-235661729-C-T | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235661978-C-T | Chédiak-Higashi syndrome | Uncertain significance (Jan 12, 2018) | ||
1-235662019-G-A | Chédiak-Higashi syndrome | Uncertain significance (Jan 12, 2018) | ||
1-235662033-C-T | Chédiak-Higashi syndrome | Uncertain significance (Jan 12, 2018) | ||
1-235662049-C-G | Chédiak-Higashi syndrome | Conflicting classifications of pathogenicity (Jan 01, 2023) | ||
1-235662067-C-G | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235662109-T-C | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235662116-T-C | Chédiak-Higashi syndrome | Uncertain significance (Jan 12, 2018) | ||
1-235662131-T-C | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235662215-C-T | Chédiak-Higashi syndrome | Benign (Jan 12, 2018) | ||
1-235662228-A-G | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235662246-A-G | Chédiak-Higashi syndrome | Uncertain significance (Jan 13, 2018) | ||
1-235662255-C-A | Chédiak-Higashi syndrome | Benign (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LYST | protein_coding | protein_coding | ENST00000389794 | 51 | 222600 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0150 | 0.985 | 125658 | 0 | 90 | 125748 | 0.000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.41 | 1758 | 1.93e+3 | 0.910 | 0.000101 | 25039 |
Missense in Polyphen | 592 | 754.77 | 0.78434 | 9855 | ||
Synonymous | -0.232 | 706 | 698 | 1.01 | 0.0000375 | 7172 |
Loss of Function | 9.58 | 44 | 184 | 0.239 | 0.0000104 | 2282 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000998 | 0.000934 |
Ashkenazi Jewish | 0.0000993 | 0.0000992 |
East Asian | 0.000329 | 0.000326 |
Finnish | 0.000555 | 0.000554 |
European (Non-Finnish) | 0.000344 | 0.000325 |
Middle Eastern | 0.000329 | 0.000326 |
South Asian | 0.000294 | 0.000294 |
Other | 0.000655 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: May be required for sorting endosomal resident proteins into late multivesicular endosomes by a mechanism involving microtubules.;
Intolerance Scores
- loftool
- 0.601
- rvis_EVS
- -3.04
- rvis_percentile_EVS
- 0.5
Haploinsufficiency Scores
- pHI
- 0.193
- hipred
- Y
- hipred_score
- 0.530
- ghis
- 0.545
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.498
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Lyst
- Phenotype
- craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; neoplasm; pigmentation phenotype; hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; vision/eye phenotype; immune system phenotype; renal/urinary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Zebrafish Information Network
- Gene name
- lyst
- Affected structure
- liver
- Phenotype tag
- abnormal
- Phenotype quality
- fatty
Gene ontology
- Biological process
- lysosome organization;protein transport;leukocyte chemotaxis;melanosome organization;endosome to lysosome transport via multivesicular body sorting pathway;mast cell secretory granule organization;natural killer cell mediated cytotoxicity;defense response to bacterium;defense response to protozoan;pigmentation;defense response to virus
- Cellular component
- cytoplasm;microtubule cytoskeleton
- Molecular function
- protein binding